我国自主研发肿瘤电场治疗产品上市 将进一步提升疗效降低成本

Core Viewpoint - The approval of China's first glioblastoma electric field therapy system marks a significant breakthrough in the treatment of high-difficulty brain tumors, enhancing survival rates for patients [1][2] Group 1: Product Approval and Impact - The electric field therapy system has received approval from the National Medical Products Administration, representing a major advancement in the field of brain tumor treatment [1] - Clinical trials indicate that for newly diagnosed glioblastoma patients, the median survival time can be extended from approximately 15 months to 31.11 months when combined with standard surgery and radiochemotherapy [1] - The median progression-free survival time reached 12.91 months, showcasing the effectiveness of the treatment [1] Group 2: Treatment Methodology and Benefits - The treatment is a non-invasive physical method that does not affect the patient's quality of life and avoids the side effects associated with traditional drug therapies [1] - The system allows for home treatment, significantly improving treatment adherence and preserving the dignity of patients [1] Group 3: Market and Accessibility - The high cost of imported electric field therapy devices, often exceeding one million yuan annually, has previously limited access for most patients [2] - The successful launch of the domestic device is a result of a nine-year collaborative effort among domestic "production, learning, research, and medical" teams, achieving complete autonomy from core technology to clinical application [2] - The introduction of this domestic product is expected to lower treatment costs and significantly enhance accessibility for patients [2] Group 4: Future Developments - A new generation of personalized precision electric field therapy based on genomics is currently in preclinical research, promising to further improve treatment efficacy in the future [2] - The clinical trial was led by the Capital Medical University affiliated Beijing Tiantan Hospital, with participation from 11 medical institutions, indicating a strong collaborative effort in the medical community [2]